We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.25 | -6.58% | 17.75 | 17.50 | 18.00 | 18.25 | 17.75 | 18.25 | 151,163 | 10:30:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/11/2023 11:22 | That's a great idea. It's unfortunate they never thought of it | vlad the impaler | |
25/11/2023 07:54 | Personally I wouldn’t start up an AIM venture without my own remote controlled market maker, if there is such a thing? I’d want a multi bagger on an RNS Reach, with gerbil distribution waiting at the top via podcast. I doubt they would listen to me here tho | kreature | |
25/11/2023 07:20 | TW still harping on OPTI/SBTX. Having been caught out (nicely), by OPTI - he bought at 7p, one would have thought that he should sell? Like RRR, he is out of the picture, face saving. SBTX - Ganging up with OPTI boss now, give the dog a bone. Wellbeing, try sprouts once a week? Pepsi max, sugar free, better than the real stuff. Someone got there before you, moons ago. Dream on | dudishes | |
22/11/2023 22:20 | Great discussion here, thanks all | kreature | |
22/11/2023 19:24 | It was one of the more pleasing de-risking strategies 😂 | thanatos abyss | |
22/11/2023 19:16 | Fk off II. It's great to see the award/winning of a grant for something that could possibly save millions of lives, and aid SP | vlad the impaler | |
22/11/2023 19:12 | Sorry , wrong person and thread and company | institutional investments | |
22/11/2023 19:11 | On a totally different topic, I'm just wondering how do grants get distributed without financial conflict of interest for the granting fund | institutional investments | |
22/11/2023 19:10 | Is he still a shareholder? | institutional investments | |
22/11/2023 19:09 | University of Reading has provided a grant under the Biotechnology and Biological Science Research Council (BBSRC) to fund a research project on WellBiome®. The research project will be carried out by the University of Leeds | institutional investments | |
22/11/2023 19:08 | The University of Reading OPTIBIOTIX HEALTH PLC Greater Leeds Area .... I can't spot any correlations in the RNS | institutional investments | |
22/11/2023 19:06 | "University of Reading has provided a grant" Is Sean Christie still a Ned here? | institutional investments | |
22/11/2023 08:01 | Yep, can see the share price rising on that today, prob already in the bag, as good as an RNS reach | kreature | |
22/11/2023 07:38 | Already in the vault haha | institutional investments | |
22/11/2023 07:16 | ‘ This is anticipated to provide further substantiation of existing health claims in international markets.’ No doubt about that discovery | kreature | |
22/11/2023 07:09 | The research project will be carried out by the University of Leeds and provides £55,451 to assess the ability of WellBiome®, a new prebiotic and mineral complex recently launched by OptiBiotix, to improve gut health and wellbeing. The grant will investigate WellBiome's® impact on the gut microbiome throughout the digestive tract and add to the existing scientific and clinical evidence. This is anticipated to provide further substantiation of existing health claims in international markets. ??? | institutional investments | |
19/11/2023 22:49 | Tick up for the generous financial advice | kreature | |
19/11/2023 22:48 | Well I listened to his disclaimer . I ignored him and did my own research. Then I continued ignoring him | thanatos abyss |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions